AMERICAN CENTURY COMPANIES INC
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 748054
KANSAS CITY, MO
Position in AVIR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$793,555
-$106,142 QoQ
Shares Held
170,657
+2.0% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 124 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. AVIR ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in AVIR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $793,555 | 170,657 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $899,697 | 167,230 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $608,063 | 170,326 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $526,889 | 181,686 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $625,647 | 173,791 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $486,954 | 162,861 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $486,403 | 145,195 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $479,706 | 143,196 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $414,309 | 125,169 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $441,402 | 109,258 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $240,199 | 78,754 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $167,679 | 55,893 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $128,618 | 34,390 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $63,763 | 19,034 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $83,516 | 17,363 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $88,803 | 15,607 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $89,772 | 12,644 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $241,971 | 33,514 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $526,807 | 58,927 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $2,388,567 | 68,128 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||